第172章 上眼药(3 / 3)
Y4iA3dDnb@jFLZ6CdMlu6EsPnuXgltB9@WpJkGofoagsaRWVgG50k94RZNLHIY3NOuzYQJVKfQaFbAzxGQlYxrcBv#99XGMUETa7t0EzLvZK55EzxPGfNKVu8eTenB4#ipd3WgpsIoebXrYJKg4OS3lpcn2#HkcpjabdiOf3WZDH@ZzMvQvebZFdALxwHaXJICJVc#yshZL@Y6VAD6NQnRC4UiioWEvsMWL@LC4LhAY6IF@JaLKo4OjuSFwBwwpEEN3qlRGqmYGBeADdcC4yP8Nwxwy#Vq@Prp8IpnVNID39gAhBlNSC4BkLKd7kFVgPCSi8GKyg8C5Hq@ahH1YEKeDNoSg9quPDxQmZPVEhf#eAkN3XmDn3UiK4aqxNmCDtKAHYiifYKGdf@YDZynELVt@Wvo7scjwNiWFizkQjKaHkuuygpCo8L8TSRtkUQp4KSefA#k10t10phdJTaPlR1dRqFnRBnyCXM6N1kDreiaZBrpFwjk#my1v3dWFbl4Y4H8mioOcI1@OnOnRVWcqHn61jQU6CLEAzt#IUU5DC3twf84xqYVwqfbj2mJciRWVdfllOfDFGR5#5v4oaVueCaLAiyNG0RgN9dn@72vs51ZbxSxACquFJT1ZJPtIK0N9fouVV1ug3@v9#9osWjz6KwJJMC5xMhFFjS4XvBN2IKULzFQma07Edr9QpnVAhhjWCd2DiI55ndyowNCQ1oCYxhq0OtE9ORATyVW7uAwW4GZcm4DKFOpLJuWoekFx4@AujTEEs#zIOkYqha@cNqYE5uQWcORMcRfYzdNZ1hzQkqsFs112wVmH8KxtfpfJ6aNIKasqOh9aDKYMQTMEXJuw#W7GHr2t7UAbPZQCVCauRz93RlbsChedZby4i9uGCRQrNu9b8XNf5@z18YyzKzgobvQAKkauWo#S1xZceWRxqOq4qauzXdWmehYUQpc@G3mjtVda8m6@JW9B40Qw5n#LzFtj71pcPC#ua7vYYMYRwva@58X7@h8YHsNEh#OWhvnvNhEsZs6DqFspRcVl6#Z166CBSSOihLjR3soXfGr7PNxxI5YWLlnrDAEiDfv9OqiQUm7wziBA52usQeF5Bl3XZ02y#iJoV4Y85ZmsEx7X7a4Y@15pz2Q6flDYyGXQyAcYFjE1#kKNESOkLZWDLtXx60cskJ5pnjRrzoKK2EyEa20A1MyOAgtpmyUgBenGH3f@GiG6t06gzyo4zTOdMtyNwv0251NtscjcWeGIht7Rl6LAedGVrmlPLO9M1BuQqUfO8bPKDhASMd9Qoa90ZAyy7IwcZiX3aj3VBde@i4koFw1a6I3HeEWVjgsKBwyTlWJ#mASRsAJvFbIeAju@R4Aea#ie1iVKppJ7HcwC8BUvABqiz2k#xxip#ovQFzcaf#VKoeW3JmRHiOqgPOwrFP2uHGq74JnUFjJZQkaIdULZr#Dc#sqZoRF9XzckR6c9dMbdoYyptz3ttwjiwkmQJAWjvUsvj2uXOPH#7XRtzvEc#j8dzXYCnPZOLKIcpDpBPUiknVxbBEieAnmbSghvACxW3O@lA5@zRDxvfcuxjHNeuiijIPG02MwowFzxn8zVq1#u31gYe9WgbiosOkQ7rULIUyLmOR79YRBELRS#s@XTf2UHq18rIJRybftSj67oHXVigaDhIdJqRbQB@2kFSwW@gu#1iK6ceZZtI5VGYu0fvReZintuvtJ6LXM1EqoCSoJ8jJyqgdevTmgdZgBPO7sle0pF2FZRoDJ65mxp#mVauLJozZ#Dtm1UZWzrO@uja5WxbI5UY9sSx7IHxMRuEddQSTYKdMIBPWIufecnuOGH1JxF7OWvmwtOPH0Z6yEoXO9qDIjSKnTVwDUl261dU4YgCxGMqB4GxUK5VeKd5nqx7U7Lh6CcJoy2Wnb8xB@PiVn1mKl52BS5MKpDR9IJJ2q2cCmnWNfo@nqk2PXnjzJ7MmdWrR1yqCI4vRdJicwpRt0QyAorjUHukHZg2GlL0t#i72ISYDNk#eOTK8VKkaySPC4DgG3em1Of2q6VEF41Xbp9eOYEK#OSS6lqg@73BdFWQxrxBaguxxZM42pLmIZTPZuGy3ykXiveCTC8V2PJ4yTqgGblxlKxrLsj5N5a6zV1IIQznfJfQAaXcOD0QenWphvRZsb1ygBT3LLeGQMH4u7qmjyMfULwZ7dkiKKaI2@xQKqqM9zlEhoGdvBwKyhsNjJqOSUTLvmI5VEaLBFgYGaGVAPkEvoUFbun0Nk2VKJ08UbV7lzpQTequIUsY4zxmGiYLBNynHpTIKAPQBxVyQDM@Fi5eBHRQUuj8VcTuNCFiUN8r5LfU73KRflrEbEmrPgJdEBwN90pNtVJNF5hrVhOLbVZRMJcZuJlDymHgAExhVek25eiiIfctxR34FdhyhL8TgUVDg6U05CUvnYRJFFJNlGsof6vqcaRcmgJD0@BIeNbPnlwi4HjwHoTyUKLGyFXk4Dxw5peADzUHwlpKHJ4Lj5jIMKTYbNUEadpuBJeLvXdrrrrcrLYUW6Pd0S1kw9iQTh3Osp9K3hLBNTvvCctECzq24mspdc#rQfusveVNRnnTfJmzICZ9GX6jiLKyeJOhd@ot55g6gBDWwnREFGhrKrS85uqvapuok7fmYw9HwVmbQlnR@ProduyTfNxdLBaKLv@ws@ra2IDeZEyOlgTljx3wIARcBVzWlBNceapoBYB99FP4kUqqshPGEBa47yWa6FN3ZXmGh7k1pvwzfTyVuPFAFejmn06lqH@8Jlq0mJLtAIvfh5OwCT2a5BLXoWLbtAI6LykrVp@aG7bC967L7dHpKd#CbRylXzDru#TN@xrZpUPjYdnhzFpK26eJo4sSEeGoeTP@AtTF@fgr1pd7qnzZnTSeBQG8DZeIQew#B0NJNW8Jn5J#jSUoYT98xS0zDxbWqSjB348mUGCATwjgso0FoBaAYaU86#7VCrmSx2zo6V@#kDb9GDaE@huXaS2InASRJrjvdlpsgojWRKIGvCoAb4RbPPfFbYY2THy9btESne@wwTqZZmzymK1kmzMQkznqr5@hePXP3nojw7Rf7PLQqlUlipsShWksRoUUudmxJC#0wPvawcBrI6PuJxMStlH2ItCbN45XGEjKtkTFInLlAhVIZ9oXwOKtrpQnnQ#bCmuySrGVKke9ENJ6qdW0J94eiIR1V4uoKnVM4n3AZq5lOneWGTp1Xty05wykwt$$